Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: Eur J Clin Pharmacol. 2007 Dec 19;64(2):207–216. doi: 10.1007/s00228-007-0427-9

Fig. 3.

Fig. 3

Response to intravenous levodopa challenges (at 8 and 80 h) before (open circles) and after 4 years (crosses) of oral levodopa treatment. From [3]